Curry Barker’s New Horror Film with Universal & Blumhouse

Source: Variety

Summary

Curry Barker’s third film, an original horror project, is set to be produced by Universal and Blumhouse Atomic Monster. Following the success of his debut feature ‘Obsession,’ Barker will take on writing, directing, and producing responsibilities for this new venture.

Why It Matters

This film represents a significant collaboration between a rising filmmaker and established production powerhouses, underscoring the increasing demand for innovative horror content. By fusing Barker’s creative vision with the resources of Universal and Blumhouse, this project has the potential to push the boundaries of the genre and attract a wide audience.

Read the full article →

  • Related Posts

    Tay Keith, Producer of ‘Sicko Mode,’ Dies at 29

    Tay Keith, renowned Grammy-nominated producer known for his work on Travis Scott’s track “Sicko Mode,” was found dead at the age of 29 in his Tennessee apartment. His sudden passing has shocked the music community, highlighting the tragic loss of a rising talent in the industry.

    Margo Martindale Shines in ‘The Long Haul’ Performance

    Margo Martindale delivers an exceptional performance in ‘The Long Haul,’ showcasing her talent in an unforgettable role. As audiences anticipate her next appearance in ‘All’s Fair,’ the question remains: will distributors recognize this cinematic gem?

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Vance Addresses GOP Concerns on Iran Deal

    Vance Addresses GOP Concerns on Iran Deal

    Beware of the Jury Duty Scam: Stay Informed

    Beware of the Jury Duty Scam: Stay Informed

    Trump Awards Medals of Honor to War Heroes

    Trump Awards Medals of Honor to War Heroes

    Unfinished Work of Freedom 161 Years After Juneteenth

    Thailand Attracts Capital Inflows Amid Indonesia’s Outflows

    Thailand Attracts Capital Inflows Amid Indonesia’s Outflows

    US Investigates Germany Over Pharma Pricing Tariffs

    US Investigates Germany Over Pharma Pricing Tariffs